
Overview
Simpa S. Salami, M.D., M.P.H. is a fellowship-trained, board-certified Urologic Oncologist and Associate Professor of Urology at the University of Michigan. He obtained his medical degree from the College of Medicine, University of Ibadan, Nigeria. Thereafter, he completed a Master of Public Health program at Harvard University, General Surgery Internship at the Brigham and Women’s Hospital in Boston, Urology Residency at Hofstra Northwell Health School of Medicine in New York, and Urologic Oncology Fellowship at the University of Michigan in Ann Arbor, Michigan. Dr. Salami’s clinical expertise is in the minimally invasive surgical treatment of prostate and kidney cancer. As a translational surgeon-scientist, his laboratory focuses on developing novel cancer biomarkers to overcome tumor heterogeneity and multifocality as well as elucidate optimal paradigms for early detection of urologic cancers, risk stratification, prognostication, and prediction of treatment response. Dr. Salami’s lab collaborates with investigators all over the world to understand the molecular underpinnings of urologic cancer and associated disparities. Dr. Salami is a recipient of several awards including the: Harvard University Presidential Scholar, Prostate Cancer Foundation Young Investigator, American Urological Association (AUA) Urology Care Foundation (UCF) Research Scholar, AUA UCF Rising Stars in Urologic Research, Harold Amos Medical Faculty Development Fellowship, Rogel Cancer Center Scholar, Society of Urologic Oncology Young Investigator, NCI R37 MERIT and 2024 AUA Gold Cystoscope Awards. Most recently, he was named an inaugural Biden White House Cancer Moonshot Scholar. He has served on several National guideline committees, such as the AUA Prostate Cancer Early Detection Guidelines, the NCCN Prostate Cancer Early Detection Guidelines, and the Society of Nuclear Medicine and Imaging PSMA PET Appropriate Use Criteria Working Group. His research is supported by multiple sources and includes funding from the Department of Defense, National Cancer Institute, and the Prostate Cancer Foundation.
Dr. Salami is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Nephrectomy, and Prostatectomy.
Dr. Salami is board certified in Urology. He is actively involved in clinical research, co-authoring 98 peer reviewed articles.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- POS
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1500 E Medical Center Dr, Floor 2 Reception C, Ann Arbor, MI 48109
380 Parkland Plaza Ste 210, Floor 2, Ann Arbor, MI 48103
Additional Areas of Focus
Dr. Salami has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Taubman Center
After graduating from the University of Leeds, Dr. Ghani completed basic surgical training in Edinburgh followed by urological surgery training in London. He was awarded a Master of Surgery thesis from the University of London for research on percutaneous renal stone surgery. Following completion of sub-specialist training in Endourology at the Stone Unit at Guy’s Hospital, London, Dr. Ghani was awarded The Urology Foundation Scholarship and undertook fellowship training in robotic surgery at the Vattikuti Urology Institute, Henry Ford Hospital, Detroit.He joined the University of Michigan in 2013 and leads the Endourology program at the Ann Arbor VA Healthcare System. He treats patients with kidney problems: stones, cancer and obstruction. Dr Ghani has authored over 200 peer-reviewed articles, and his research focuses on endoscopic stone surgery and quality improvement. Specifically, he has been advancing a Dusting technique for ureteroscopy and has extramural funding to study laser lithotripsy in the laboratory. He is the Course Director of the annual Developments in Ureteroscopic Stone Treatment (D.U.S.T.) symposium, an international meeting that has exposed hundreds of urologists to advanced ureteroscopy techniques. He is also the Course Director of the American Urological Association annual course, Dust or Bust.In addition, Dr Ghani serves as the Director of the Michigan Urological Surgery Improvement Collaborative (MUSIC), which is a consortium of 46 urology practices aiming to improve the quality of care for patients with prostate cancer, kidney stones, and kidney cancer. Within MUSIC, he is the principal investigator of two randomized clinical trials assessing patient health-related quality of life and healthcare use after ureteroscopy. Dr. Ghani has received numerous prizes for his presentations and research from the American Urological Association, Endourological Society, European Association of Urology, and has lectured and taught surgeons throughout the world. He is an Assistant Editor for the Journal of Urology and serves on the editorial board of Nature Reviews Urology. Dr. Ghani is highly rated in 31 conditions, according to our data. His clinical expertise encompasses Kidney Stones, Urinary Tract Infection (UTI), Prostate Cancer, Lithotripsy, and Ureteroscopy.
Taubman Center
Dr. Dauw received his medical degree from Loyola University in Chicago graduating Magna Cum Laude. He then completed a urology residency at The University of Michigan. Following this, he pursued subspecialty training in endourology with Dr. James Lingeman at Methodist Hospital in Indianapolis. His primary clinical interests include the medical and surgical management of kidney stones, in particular, endourological management of complex renal calculi. He is also one of few U.S. providers with expertise in holmium laser enucleation of the prostate (HoLEP), a state-of-the-art, minimally invasive surgical treatment for men with an enlarged prostate. His research interests focus on improving the quality of care for patients with kidney stones as well as understanding outcomes associated with commonly performed endourological surgeries. Dr. Dauw is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Kidney Stones, Perirenal Abscess, Folliculitis, Ureteroscopy, and Lithotripsy. Dr. Dauw is board certified in Urology.
Rogel Cancer Center
Dr. Jeffery Montgomery's clinical interests include the diagnosis and management of bladder, prostate, and penile and testicular cancers. With his advanced training in urologic oncology and minimally invasive surgical techniques, such as robotic, laparoscopic and complex open surgery, he is able to deliver state-of-the-art care to his patients. He has expertise in state-of-the-art diagnostics for prostate cancer, including prostate MRI, fusion prostate biopsy, and transperineal standard and fusion prostate biopsies. He has extensive experience performing advanced robotic surgery, including prostatectomy, cystectomy with intra-corporeal urinary diversions, and inguinal lymph node dissections. Dr. Montgomery's research focuses on improving the quality and efficiency of urologic oncology disease management. Dr. Montgomery is a Michigan native and earned his undergraduate degree from the University of Michigan. He then went on to complete his medical education at the Columbia University College of Physicians and Surgeons in New York before finishing his Urology residency at the University of Michigan. He completed his urologic oncology fellowship at the University of Texas MD Anderson Cancer Center. Dr. Montgomery is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Prostate Cancer, Cystectomy, and Prostatectomy. Dr. Montgomery is board certified in Urology.
Frequently Asked Questions about Dr. Simpa S. Salami
How do I make an appointment with Dr. Simpa S. Salami?
You can book an appointment with Dr. Simpa S. Salami by calling their office at 734-936-7030. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Simpa S. Salami a top-rated expert for Prostate Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Simpa S. Salami is classified as an Elite expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Simpa S. Salami specialize in?
While Dr. Simpa S. Salami is a Urology, they have specific expertise in Prostate Cancer, Renal Cell Carcinoma (RCC), and Familial Prostate Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Urology.
Does Dr. Simpa S. Salami participate in research or clinical trials?
Yes. Dr. Simpa S. Salami has published 98 articles and abstracts on conditions like Prostate Cancer. You can view a list of Dr. Simpa S. Salami's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Simpa S. Salami accept my insurance?
Dr. Simpa S. Salami accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 734-936-7030 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Prostate CancerDr. Salami isElite. Learn about Prostate Cancer.
- Renal Cell Carcinoma (RCC)Dr. Salami isElite. Learn about Renal Cell Carcinoma (RCC).
- Distinguished
- Familial Prostate CancerDr. Salami isDistinguished. Learn about Familial Prostate Cancer.
- Familial Wilms Tumor 2Dr. Salami isDistinguished. Learn about Familial Wilms Tumor 2.
- UreteroceleDr. Salami isDistinguished. Learn about Ureterocele.
- Advanced
- Chromophobe Renal Cell CarcinomaDr. Salami isAdvanced. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Salami isAdvanced. Learn about Clear Cell Sarcoma.
- NephrectomyDr. Salami isAdvanced. Learn about Nephrectomy.
- ProstatectomyDr. Salami isAdvanced. Learn about Prostatectomy.
- Wilms TumorDr. Salami isAdvanced. Learn about Wilms Tumor.
- WT1-Related Wilms Tumor SyndromesDr. Salami isAdvanced. Learn about WT1-Related Wilms Tumor Syndromes.
- Experienced
- Bilateral HydronephrosisDr. Salami isExperienced. Learn about Bilateral Hydronephrosis.
- Bladder CancerDr. Salami isExperienced. Learn about Bladder Cancer.
- EmpyemaDr. Salami isExperienced. Learn about Empyema.
- EndoscopyDr. Salami isExperienced. Learn about Endoscopy.
- HydronephrosisDr. Salami isExperienced. Learn about Hydronephrosis.
- Intussusception in ChildrenDr. Salami isExperienced. Learn about Intussusception in Children.


